← All organizations

Synthorx, Inc.

Synthorx, Inc.

For profitWebsite ↗

Also known as: Synthorx, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Jun 20, 2019

Acquired by Sanofi-Aventis on Dec 9, 2019

Timeline

2010s

Jan 1, 2014
Synthorx, Inc.— Founded
Dec 9, 2019
Sanofi-Aventis— Acquired By

Drugs by trial phase (1 distinct, 1 trials)

Phase 2 (1 own, 0 via acquisition)

thor-707

Indications

Studied for

Neoplasms

Recent trials (2)

NCT04009681Lead sponsorPhase 1/Phase 2Jun 20, 2019
NCT04009681Study directorPhase 1/Phase 2Jun 20, 2019

Details

Founded: La Jolla, CA, US Jan 1, 2014
Last known activity: Jun 20, 2019